{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:39Z","timestamp":1791273099589,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002001","name":"DH | NIHR | Health Services and Delivery Research Programme","doi-asserted-by":"publisher","award":["HSDR NIHR132459"],"award-info":[{"award-number":["HSDR NIHR132459"]}],"id":[{"id":"10.13039\/501100002001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002001","name":"DH | NIHR | Health Services and Delivery Research Programme","doi-asserted-by":"publisher","award":["HSDR NIHR132459"],"award-info":[{"award-number":["HSDR NIHR132459"]}],"id":[{"id":"10.13039\/501100002001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002001","name":"DH | NIHR | Health Services and Delivery Research Programme","doi-asserted-by":"publisher","award":["HSDR NIHR132459"],"award-info":[{"award-number":["HSDR NIHR132459"]}],"id":[{"id":"10.13039\/501100002001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002001","name":"DH | NIHR | Health Services and Delivery Research Programme","doi-asserted-by":"publisher","award":["HSDR NIHR132459"],"award-info":[{"award-number":["HSDR NIHR132459"]}],"id":[{"id":"10.13039\/501100002001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,10,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Older patients are routinely excluded from clinical research, limiting understanding of recurrence and mortality in colorectal cancer (CRC) patients over 75 who undergo curative major resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using linked data from national cancer, treatment and administrative datasets, we estimated recurrence, CRC-related and non-CRC mortality to 5 years after surgery for patients selected for curative resection in England between 2014 and 2020, who survived &gt;9months. Recurrence was defined using diagnostic and treatment codes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>50,480 patients had curative resection, 15,496 (30.7%) aged &gt;75. Recurrence-free survival at 5-years after resection was 66.2%\u00a0(95%CI: 65.4%, 67.0%) for patients aged &gt;75 and 77.4%\u00a0(77.0%, 77.9%) for patients aged 18-75. By 5-years, 13.3%\u00a0(12.7%, 13.9%) of the older group had died from CRC and 14.2%\u00a0(13.6%, 14.8%) from non-CRC causes, compared with 7.7%\u00a0(7.4%, 8.0%) and 3.6%\u00a0(3.4%, 3.8%) respectively in the younger group. Recurrence-free survival was 22% lower for cancer stage 3 versus stage 1, and 12\u201313% lower for patients aged &gt;75 versus \u226475.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cancer stage was the strongest predictor of recurrence and CRC-related death. In patients selected for surgery, those aged&gt;75 had similar recurrence risk to younger patients, but higher risk of death following recurrence, and were as likely to die from other causes as from CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03553-4","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:18:44Z","timestamp":1784643524000},"page":"1267-1275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of older age and stage on risk of recurrence and mortality following curative resection, in a national cohort of patients with colorectal cancer"],"prefix":"10.1038","volume":"135","author":[{"given":"Orouba","family":"Almilaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-6323","authenticated-orcid":false,"given":"Kate","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-2335","authenticated-orcid":false,"given":"Jan","family":"Van Der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fearnhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6666-4868","authenticated-orcid":false,"given":"Michael","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-966X","authenticated-orcid":false,"given":"Linda D.","family":"Sharples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"3553_CR1","unstructured":"Cancer Research UK. Bowel cancer statistics. 2026. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer"},{"key":"3553_CR2","unstructured":"National Bowel Cancer Audit. State of the Nation: Supplementary Results 2024 (Version 1.0, 09.01.2025). National Cancer Audit Collaborating Centre; 2025. https:\/\/www.natcan.org.uk\/wp-content\/uploads\/2025\/07\/NBOCA-SotN-Supplementary-Results-2024_v1.0_09.01.2025-4.pdf"},{"key":"3553_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101093","volume":"47","author":"J Nors","year":"2024","unstructured":"Nors J, Gotschalck KA, Erichsen R, Andersen CL. Risk of recurrence in early-onset versus late-onset non-metastatic colorectal cancer, 2004\u20132019: a nationwide cohort study. Lancet Reg Health Eur. 2024;47:101093.","journal-title":"Lancet Reg Health Eur"},{"key":"3553_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2025.102962","volume":"100","author":"O Almilaji","year":"2026","unstructured":"Almilaji O, Sharples L, Aggarwal A, Cromwell D, Horgan K, Braun M, et al. A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data. Cancer Epidemiol. 2026;100:102962. Feb.","journal-title":"Cancer Epidemiol"},{"key":"3553_CR5","first-page":"78","volume":"71","author":"MS Sedrak","year":"2021","unstructured":"Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD, et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71:78\u201392.","journal-title":"CA Cancer J Clin"},{"key":"3553_CR6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/jama.2018.12368","volume":"320","author":"MA Bernard","year":"2018","unstructured":"Bernard MA, Clayton JA, Lauer MS. Inclusion across the lifespan: NIH policy for clinical research. JAMA. 2018;320:1535\u20136.","journal-title":"JAMA"},{"key":"3553_CR7","unstructured":"National Institute for Health and Care Research. Health datasets to conduct research. 2025 [cited 2025 Aug 26]. Available from: https:\/\/www.nihr.ac.uk\/support-and-services\/industry\/explore\/health-datasets"},{"key":"3553_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ije\/dyz076","volume":"49","author":"KE Henson","year":"2019","unstructured":"Henson KE, Elliss-Brookes L, Coupland VH, Payne E, Vernon S, Rous B, et al. Data resource profile: National Cancer Registration Dataset in England. Int J Epidemiol. 2019;49:16\u201316h.","journal-title":"Int J Epidemiol"},{"key":"3553_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/ije\/dyx015","volume":"46","author":"A Herbert","year":"2017","unstructured":"Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P. Data resource profile: Hospital Episode Statistics Admitted Patient Care (HES APC). Int J Epidemiol. 2017;46:1093\u20131093i.","journal-title":"Int J Epidemiol"},{"key":"3553_CR10","doi-asserted-by":"publisher","first-page":"e070699","DOI":"10.1136\/bmjopen-2022-070699","volume":"13","author":"S Sandhu","year":"2023","unstructured":"Sandhu S, Sharpe M, Findlay U, Roe C, Broggio J, Spencer K, et al. Cohort profile: Radiotherapy Dataset (RTDS) in England. BMJ Open. 2023;13:e070699.","journal-title":"BMJ Open"},{"key":"3553_CR11","unstructured":"National Cancer Registration and Analysis Service. Systemic Anti-Cancer Therapy (SACT) Dataset. [cited 2026 Apr]. Available from: https:\/\/digital.nhs.uk\/ndrs\/data\/data-sets\/sact"},{"key":"3553_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13777-x","volume":"25","author":"O Almilaji","year":"2025","unstructured":"Almilaji O, Sharples L, Aggarwal A, Cromwell D, Horgan K, Braun M, et al. Value of hospital administrative data linked to national cancer registry records to identify metastatic disease at time of primary diagnosis in colorectal cancer patients: a study using national data in England. BMC Cancer. 2025;25:407.","journal-title":"BMC Cancer"},{"key":"3553_CR13","unstructured":"World Health Organization. ICD-10: International statistical classification of diseases and related health problems. 10th revision. Geneva: WHO; 2004. https:\/\/iris.who.int\/handle\/10665\/42980"},{"key":"3553_CR14","unstructured":"NHS Digital. National Clinical Coding Standards OPCS-4. Terminology and Classifications Delivery Service; 2019. https:\/\/isd.digital.nhs.uk\/trud\/users\/guest\/filters\/0\/categories\/10"},{"key":"3553_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2307\/2333101","volume":"40","author":"A Stuart","year":"1953","unstructured":"Stuart A. The estimation and comparison of strengths of association in contingency tables. Biometrika. 1953;40:105\u201310.","journal-title":"Biometrika"},{"key":"3553_CR16","unstructured":"Therneau TM, Grambsch PM Modelling survival data: extending the Cox model. New York: Springer; 2013"},{"key":"3553_CR17","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389\u2013430.","journal-title":"Stat Med"},{"key":"3553_CR18","unstructured":"Therneau T, Crowson C, Atkinson E Competing risks and multistate models. 2024. https:\/\/cran.r-universe.dev\/articles\/survivalVignettes\/tutorial.html"},{"key":"3553_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/01621459.1985.10478195","volume":"80","author":"JD Kalbfleisch","year":"1985","unstructured":"Kalbfleisch JD, Lawless JF. The analysis of panel data under a Markov assumption. J Am Stat Assoc. 1985;80:863\u201371.","journal-title":"J Am Stat Assoc"},{"key":"3553_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2307\/2530699","volume":"42","author":"R Kay","year":"1986","unstructured":"Kay R. A Markov model for analysing cancer markers and disease states in survival studies. Biometrics. 1986;42:855\u201365.","journal-title":"Biometrics"},{"key":"3553_CR21","unstructured":"Jackson C msm: Multi-state Markov and hidden Markov models in continuous time. Version 12. CRAN; 2024. https:\/\/CRAN.R-project.org\/package=msm"},{"key":"3553_CR22","unstructured":"Cancer Research UK. Cancer grades. 2025. https:\/\/www.cancerresearchuk.org\/about-cancer\/what-is-cancer\/cancer-grading"},{"key":"3553_CR23","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1158\/1055-9965.EPI-20-0490","volume":"29","author":"N Kunst","year":"2020","unstructured":"Kunst N, Alarid-Escudero F, Aas E, Coup\u00e9 VMH, Schrag D, Kuntz KM. Estimating population-based recurrence rates of colorectal cancer over time in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29:2710\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3553_CR24","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/ijc.26192","volume":"131","author":"H Brenner","year":"2012","unstructured":"Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer. 2012;131:1649\u201358.","journal-title":"Int J Cancer"},{"key":"3553_CR25","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41416-022-01718-5","volume":"126","author":"C Delon","year":"2022","unstructured":"Delon C, Brown KF, Payne NWS, Kotrotsios Y, Vernon S, Shelton J. Differences in cancer incidence by broad ethnic group in England, 2013-2017. Br J Cancer. 2022;126:1765\u201373.","journal-title":"Br J Cancer"},{"key":"3553_CR26","unstructured":"National Bowel Cancer Audit. Trends, characteristics and outcomes for patients diagnosed under 50 years old with metastatic colon cancer in England. 2021. https:\/\/www.natcan.org.uk\/wp-content\/uploads\/2025\/07\/Under-50s_FinalPDF.pdf"},{"key":"3553_CR27","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.3390\/cancers14246239","volume":"14","author":"C Foppa","year":"2022","unstructured":"Foppa C, Maroli A, Lauricella S, Luberto A, La Raja C, Bunino F, et al. Different oncologic outcomes in early-onset and late-onset sporadic colorectal cancer: a regression analysis on 2073 patients. Cancers (Basel). 2022;14:6239.","journal-title":"Cancers (Basel)"},{"key":"3553_CR28","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343\u201351.","journal-title":"N Engl J Med"},{"key":"3553_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S1470-2045(18)30093-7","volume":"19","author":"TJ Iveson","year":"2018","unstructured":"Iveson TJ, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, et al. 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2018;19:562\u201378.","journal-title":"Lancet Oncol"},{"key":"3553_CR30","unstructured":"Cancer Research UK. Unleashing the power of data to beat cancer: our research data strategy. 2025. Available from: https:\/\/www.cancerresearchuk.org\/sites\/default\/files\/cancer_research_uk_-_research_data_strategy.pdf"},{"key":"3553_CR31","doi-asserted-by":"crossref","unstructured":"Rashid A, Blake H, Han L, van der Meulen J, Braun MS, Fearnhead NS, et al. Association between age and resectional surgery for patients with stage II or III colorectal cancer: a national study. Br J Surg Open 2026;10:1\u201911.","DOI":"10.1093\/bjsopen\/zrag071"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03553-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03553-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03553-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:01:32Z","timestamp":1791270092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03553-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03553-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Ethical approvals were attained for this research (London School of Hygiene and Tropical Medicine (LSHTM) Ethics committee reference: 27459, and NHS Health Research Authority Research Ethics Committee (REC) reference: 21\/HRA\/5559). Ethical approvals did not require patient consent, according to the General Data Protection Regulation (GDPR) UK.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}